SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827809-17-000038
Filing Date
2017-08-08
Accepted
2017-08-08 16:30:20
Documents
67
Period of Report
2017-08-08

Document Format Files

Seq Description Document Type Size
1 10-Q nvln-063017x10q.htm 10-Q 782643
2 EXHIBIT 31.1 a20170630_exhibit311.htm EX-31.1 12408
3 EXHIBIT 31.2 a20170630_exhibit312.htm EX-31.2 12420
4 EXHIBIT 32.1 a20170630_exhibit321.htm EX-32.1 6052
5 EXHIBIT 32.2 a20170630_exhibit322.htm EX-32.2 6179
  Complete submission text file 0000827809-17-000038.txt   4034297

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aegr-20170808.xml EX-101.INS 710923
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aegr-20170808.xsd EX-101.SCH 38354
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aegr-20170808_cal.xml EX-101.CAL 71130
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aegr-20170808_def.xml EX-101.DEF 152112
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aegr-20170808_lab.xml EX-101.LAB 407907
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aegr-20170808_pre.xml EX-101.PRE 263350
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 171015216
SIC: 2834 Pharmaceutical Preparations